Return On Equity of Summit Therapeutics Inc. from 30 Jun 2019 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Summary
-
Summit Therapeutics Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2019 to 31 Dec 2025.
- Summit Therapeutics Inc. Return On Equity for the quarter ending 31 Dec 2025 was -297%, a 257% decline year-over-year.
- Summit Therapeutics Inc. annual Return On Equity for 2025 was -297%, a 257% decline from 2024.
- Summit Therapeutics Inc. annual Return On Equity for 2024 was -83%, a 85% increase from 2023.
- Summit Therapeutics Inc. annual Return On Equity for 2023 was -572%, a 582% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Summit Therapeutics Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -297% | -214% | -257% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -311% | -207% | -199% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -209% | -53% | -34% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -70% | +66% | +48% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -83% | +489% | +85% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -104% | +395% | +79% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -155% | +311% | +67% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -136% | +403% | +75% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -572% | -488% | -582% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -499% | -395% | -378% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -466% | -353% | -314% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -539% | -439% | -439% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -84% | +12% | +13% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -104% | -22% | -27% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -113% | -16% | -16% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -100% | +8.4% | +7.7% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -96% | -8.1% | -9.2% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -82% | -52% | -177% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | -97% | -71% | -276% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | -109% | -98% | -904% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -88% | 01 Oct 2020 | 31 Dec 2020 | ||
| Q3 2020 | -30% | -14% | -90% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | -26% | -10% | -68% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | -11% | 01 Jan 2020 | 31 Mar 2020 | ||
| Q3 2019 | -16% | 01 Jul 2019 | 30 Sep 2019 | ||
| Q2 2019 | -15% | 01 Apr 2019 | 30 Jun 2019 |
Summit Therapeutics Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -297% | -214% | -257% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -83% | +489% | +85% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | -572% | -488% | -582% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -84% | +12% | +13% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -96% | -8.1% | -9.2% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -88% | -32% | -58% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -56% | 01 Feb 2019 | 31 Dec 2019 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.